University of Nebraska Medical Center: Drug Added With Remdesivir Benefits Patients With COVID-19 Pneumonia
December 12, 2020
December 12, 2020
OMAHA, Nebraska, Dec. 12 -- The University of Nebraska Medical Center issued the following news release:
University of Nebraska Medical Center infectious disease physician Andre Kalil, MD, is author of a paper that shows that remdesivir and baricitinib together have benefits in treating hospitalized patients with COVID-19 pneumonia. The paper is published online in the Dec. 11 New England Journal of Medicine, which is among the most prestigious, peer-reviewed journals.
. . .
University of Nebraska Medical Center infectious disease physician Andre Kalil, MD, is author of a paper that shows that remdesivir and baricitinib together have benefits in treating hospitalized patients with COVID-19 pneumonia. The paper is published online in the Dec. 11 New England Journal of Medicine, which is among the most prestigious, peer-reviewed journals.
. . .